Centene Corporation Reports $49.7 Billion Revenue and $6.6 Billion Net Loss in Q3 2025

Centene Corporation reported significant financial results for the third quarter of 2025, with total revenues reaching $49.7 billion, an 18% increase compared to $42.0 billion in the same period last year. The company's premium and service revenues also grew by 22% year-over-year, totaling $44.9 billion. However, Centene experienced a net loss of $6.6 billion for the quarter, primarily due to a non-cash goodwill impairment of $6.7 billion. This resulted in a diluted loss per share of $13.50, a stark contrast to the earnings of $1.36 per share reported in the third quarter of 2024.

The company's financial performance reflects a notable shift from the previous fiscal period, where it reported a net income of $713 million in Q3 2024. The increase in revenues was driven by growth in the Medicare and Medicaid segments, with Medicare revenues surging by 66% to $9.4 billion, while Medicaid revenues increased by 6% to $28.0 billion. Despite the revenue growth, the health benefits ratio (HBR) rose to 92.7% from 89.2% in the prior year, indicating higher medical costs, particularly in the Marketplace and Medicaid segments.

Strategically, Centene has made several operational adjustments, including the commencement of new Medicaid contracts in various states, such as Iowa and Mississippi, which are expected to enhance its service offerings. The company also expanded its Health Insurance Marketplace product, Ambetter Health, into 60 new counties across ten states, contributing to a 29% increase in Marketplace membership year-over-year. However, the overall managed care membership decreased by 672,000 members, or 2%, primarily due to Medicaid redeterminations.

In terms of operational metrics, Centene's selling, general, and administrative (SG&A) expenses increased slightly to $3.1 billion, but the SG&A expense ratio improved to 7.0% from 8.3% in the previous year, reflecting better expense management relative to revenue growth. The company reported cash flows from operations of $4.7 billion for the nine months ended September 30, 2025, a significant increase from $741 million in the same period last year, indicating improved operational efficiency.

Looking ahead, Centene anticipates continued challenges due to regulatory changes and market conditions, particularly related to Medicaid and the Health Insurance Marketplace. The company is focused on managing medical costs and maintaining affordability for its members while navigating the implications of the One Big Beautiful Bill Act, which may affect Medicaid eligibility and funding. Despite these challenges, Centene remains committed to leveraging its extensive experience in the healthcare sector to adapt and thrive in a changing environment.